Related Experiment Video
Updated: Aug 3, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Effective Multivalent Oriented Presentation of Meningococcal NadA Antigen Trimers by Self-Assembling Ferritin
Daniele Veggi1, Lucia Dello Iacono1, Enrico Malito2
1GSK, Via Fiorentina 1, 53100 Siena, Italy.
Self-assembling ferritin nanoparticles displaying Neisseria meningitidis NadA antigens significantly boosted antibody levels and induced potent bactericidal activity in mice. This validates nanoparticles as a versatile platform for enhancing bacterial vaccine immunogenicity.
Area of Science:
- Biotechnology
- Vaccinology
- Structural Biology
Background:
- Nanoparticle-displayed viral antigens mimic virions, enhancing humoral responses.
- Bacterial antigens on self-assembling protein nanoparticles also show potent immunogenicity.
- This highlights nanoparticles as a universal platform for vaccine development.
Purpose of the Study:
- To design, structurally analyze, and assess the immunogenicity of self-assembling ferritin nanoparticles displaying Neisseria meningitidis NadA.
- To evaluate the efficacy of these nanoparticles in eliciting antibody responses and bactericidal activity.
Main Methods:
- Engineered ferritin fusion constructs with NadA fragments (head only, head with stalk).
- Expressed constructs in Escherichia coli and confirmed self-assembly into nanoparticles via Cryo-electron microscopy.
- Immunized mice and measured NadA antibody levels and complement-mediated serum bactericidal activity.
Main Results:
- Both ferritin-NadA nanoparticle designs self-assembled as expected.
- Nanoparticles induced 10- to 100-fold higher NadA antibody levels compared to NadA trimers.
- Potent complement-mediated serum bactericidal activity was observed.
Conclusions:
- Self-assembling ferritin nanoparticles effectively enhance the immunogenicity of bacterial antigens like NadA.
- This approach is broadly applicable for vaccine development, particularly for trimeric antigens.
- Nanoparticle-based vaccines offer a promising strategy for combating bacterial infections.
More Related Videos
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022